INC Research Company Updates | Glassdoor.com.au

Company Updates

  • http://glassdoor.com/slink.htm?key=vI15c

    INC boosts its outlook after another big revenue quarter

    INC Research ($INCR) is ticking up its revenue expectations for 2015 after turning in another quarter of sales growth, counting on its expanded operation to keep contracts rolling in. The CRO cleared $234.5 million in the third quarter, a 15.4% increase over the prior year that topped analysts' estimates.

  • Find job openings, INC employees and company updates when you follow us on Linkedin: http://glassdoor.com/slink.htm?key=vIphK

    INC Research

    INC Research is a leading, global full-service clinical research organization (CRO) providing the full range of Phase I to IV clinical development services for the world's pharmaceutical, biotech and medical device industries. As a therapeutically focused CRO, with a Trusted Process delivery methodology, developing the medicines people need is something we take personally.

  • Medidata Names INC Research Winner of "Trial of the Future" Award for Operational Excellence http://glassdoor.com/slink.htm?key=vIpBL

    Medidata Names INC Research Winner of "Trial of the Future" Award for Operational Excellence

    RALEIGH, N.C. and NEW YORK - October 7, 2015 - INC Research Holdings, Inc. (NASDAQ: INCR), a leading, global Phase I to IV contract research organization (CRO), and Medidata (NASDAQ: MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences, today announced that INC Research has been named the recipient of Medidata's Trial of the Future Award in the Operational Excellence category.

  • Happy World Heart Day! Meet the team leading our Cardiovascular studies:http://glassdoor.com/slink.htm?key=vI8ru

    Experienced Cardiovascular Team | INC Research

    Meet your team of cardiovascular product development specialists and therapeutic experts

  • http://glassdoor.com/slink.htm?key=vI8sF

    Patient Centered Drug Development: Educate

    Educating patients is an essential part of drug development and clinical trial process. Watch as leaders in the industry explain why communicating and educating patients is such an important part of their job. To learn more about patient centered drug development, clinical trials, and clinical research organizations visit www.acrohealth.org/

  • Get to know our Biometrics team and explore our new opportunities for programmers, biostatisticians, & project managers http://glassdoor.com/slink.htm?key=vI82B

    Experienced Biometrics Team | INC Research

    I've dedicated my career to perfecting and refining the Biometrics services. I co-founded my own Biometrics services company in the early 1990s and successfully grew it until 2005, when the company was sold to a full-service, international CRO. I've championed numerous global programs, including NDAs, in a variety of therapeutic areas.

  • “You can have your own internal passion, but it’s contagious... everyone who touches these projects has that same level of passion and same level of commitment. I’m in awe of the staff we actually have here... to them it really is personal.” -- Meghann Howland Executive Director, Clinical Development Global Head of Early Phase Oncology Meet the INC Oncology team: http://glassdoor.com/slink.htm?key=vI80Z

    VD0045 | Clinical Research Organization | Clinical Trial | Phase I-Iv Clinical | INC Research

    Questions? Meet the INC Oncology team ONCOLOGY CLINICAL TRIALS Oncology with Nicholas Kenny, PhD; Executive Vice President and General Manager, Global Oncology-Hematology, Susan Akers-Smith; Vice President, Global Oncology-Hematology; Patrick Melvin, Vice President, Oncology-Hematology; Susan Timoney, Vice President, Solid Tumors

  • INC Research CEO Jamie Macdonald will be speaking at the 5th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference. Don’t miss his panel, “Disrupting the CRO: What Will Be the CRO of the Future?” on September 10th. http://glassdoor.com/slink.htm?key=vITom

    Disruptive Innovations US

    Andreas Koester, MD, PhD VP, Clinical Trial Innovation & External Alliances Janssen Craig Lipset, MBA Head of Clinical Innovation, R&D Pfizer Komathi Stem, MS Strategic Innovation Leader Genentech/Roche Welcome to the 5th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference.

  • INC Research Pilots IAOCR Accreditation Program to Better Prepare CRAs and Clinical Staff for the Field http://glassdoor.com/slink.htm?key=vIT7m

    Accreditation of ClinOps Workforce Begins at INC

    IAOCR, an independently recognized, competence-based accreditation, consultancy and accredited training organization within the clinical research sector, announced INC Research as the first to participant in its Clinical Operations Workforce Quality Accreditation pilot. Previously, IAOCR's accreditations extended to individuals in the clinical research sector, while training programs were available to individuals and biopharma and CROs, however, this is the first accreditation for a company as a whole.

  • INC Research's commitment to maintaining first-class relationships with sites has just been reaffirmed by our 2015 SCRS Eagle Award nomination! The Eagle Awards serve to recognize sponsors and CROs that work with sites to ensure patient safety, timely enrollment, and effective communication to optimize study success. http://glassdoor.com/slink.htm?key=vITlg

    Sponsor and CRO Finalists Announced for Annual Society for Clinical Research Sites' Eagle Award

    Ellicott City, M.D., August 13, 2015 - The Society for Clinical Research Sites (SCRS), the trade organization representing over 2,600 global clinical research sites in 42 countries, announces today the finalists for the 2015 SCRS Eagle Award. The finalists were selected from a record number of nominations provided by SCRS members.

Work at INC Research? Share Your Experiences

INC Research
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or